Drug ID: | NPD2199 |
Drug Name: | Hexylcaine |
Molecular Formula: | C16H23NO2 |
Canonical SMILES: | CC(OC(=O)c1ccccc1)CNC1CCCCC1 |
Standard InCHI: | InChI=1S/C16H23NO2/c1-13(12-17-15-10-6-3-7-11-15)19-16(18)14-8-4-2-5-9-14/h2,4-5,8-9,13,15,17H,3,6-7,10-12H2,1H3 |
Standard InCHIKey: | DKLKMKYDWHYZTD-UHFFFAOYSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD; ChEMBL; IUPHAR/BPS |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DAP000506 |
DrugBank | DB00473 |
ChEMBL | CHEMBL1197 |
IUPHAR/BPS | 7196 |
PharmaGKB | PA164746489 |
KEGG Drug | |
PubChem CID | 10770 |
ChEBI | 34791 |
CAS Number | 532-77-4 |
Molecular Weight | 261.17 |
ALogP | -1.9894 |
MLogP | 2.89 |
XLogP | 4.889 |
HDA | 3 |
HBD | 1 |
Rotatable Bonds | 7 |
TPSA | 38.33 |
RO5 Violation | 0 |